Global mergers and acquisition activity will soar this year, and several names could benefit from the comeback, according to Morgan Stanley.
The firm expects global M & A volume activity to rise by 50% this year compared to 2023.
"We believe that a cyclical and structural rebound in M & A is coming," Morgan Stanley said in a note titled "Stocks with Elevated Likelihood of Receiving an Offer," which was released Monday.
Morgan Stanley pointed out that 2021 to 2023 could have seen a drop of activity worth between $4 trillion and $11 trillion.
Morgan Stanley said it has no information about M & A activity involving the companies.
Persons:
Morgan Stanley, Morgan, Stephen Ju, Morgan Stanley's
Organizations:
Health, Sarepta Therapeutics, Tenet Healthcare, Analysts, BMO Capital Markets, UBS, Hertz Global Holdings
Locations:
Europe